| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 6.992 | 9.574 | 3.332 | 0 |
| Total Income - EUR | - | - | - | 13.450 | 4.018 | 11.789 | 17.268 | 16.092 | 2.775 | 9.588 |
| Total Expenses - EUR | - | - | - | 9.346 | 6.349 | 759 | 13.912 | 6.490 | 12.032 | 9.907 |
| Gross Profit/Loss - EUR | - | - | - | 4.104 | -2.331 | 11.030 | 3.356 | 9.602 | -9.257 | -319 |
| Net Profit/Loss - EUR | - | - | - | 4.104 | -2.331 | 11.030 | 3.171 | 9.521 | -9.290 | -319 |
| Employees | - | - | - | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Gfn Bio-Prod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 8.314 | 80.787 | 79.256 | 69.678 | 69.894 | 69.682 | 69.292 |
| Current Assets | - | - | - | 4.365 | 3.579 | 5.948 | 22.328 | 39.991 | 29.942 | 28.536 |
| Inventories | - | - | - | 0 | 0 | 0 | 1.073 | 5.009 | 0 | 691 |
| Receivables | - | - | - | 0 | 0 | 0 | 6.992 | 14.560 | 14.567 | 14.456 |
| Cash | - | - | - | 4.365 | 3.579 | 5.948 | 14.263 | 20.422 | 15.375 | 13.390 |
| Shareholders Funds | - | - | - | 4.147 | 1.736 | 12.733 | 15.622 | 25.192 | 12.287 | 5.547 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 8.531 | 82.631 | 72.470 | 76.384 | 14.800 | 17.655 | 22.989 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 69.894 | 69.682 | 69.292 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Gfn Bio-Prod S.r.l.